Drugs for treatment of heart failure Flashcards
MOA of sodium nitroprusside
Release NO that causes vasodilation
Reduce preload and afterload → decrease cardiac load and BP → treat CHF
See MOA of nitrates for more detailed explanation
Adverse effects of sodium nitroprusside
- Hypotension
- Cyanide poisoning
- Methemoglobin > cellular hypoxia
Examples of Loop Diuretics (most efficacious diuretic agents)
Sulfonamide derivatives: furosemide, bumetanide
ethacrynic acid
MOA of Loop Diuretics
- Loop diuretics selectively inhibit the luminal Na+/K+/2CL- transporter in the thick ascending limb of Henle’s loop
- Loop diuretics cause an increase in Mg2+ and Ca2+ excretion
- Loop diuretics induce renal PGs synthesis. NSAIDs (aspirin, indomethacin) interfere with the actions of loop diuretics by reducing the PGs synthesis
- Furosemide increases renal blood flow
PK of Loop diuretics
- rapidly absorbed, response extremely rapid following IV injection
- DOA of furosemide: 2-3H
- eliminated by tubular secretion as well as glomerular filtration
Clinical uses of Loop Diuretics
- acute pulmonary oedema and other oedema
- acute hyperkalemia
- acute renal failure
- anion overdose: toxic ingestions of bromide, fluoride, and iodide
Adverse effects of Loop Diuretics
- hypokalemic metabolic alkalosis
- ototoxicity (avoid use together with aminoglycoside antibiotics, if possible)
- Hyperuricemia
- Hypomagnesemia
Examples of Thiazides (most widely used diuretic agents)
- Hydrochlorothiazide
- Indapamide
- Clorthalidone
MOA of Thiazides
- inhibit NaCl reabsorption by blocking the Na+/Cl- transporter
- enhances Ca2+ reabsorption in DCT
- action of thiazides depends in part on renal PGs synthesis, NSAIDs (aspirin, indomethacin) interfere with the actions of thiazide by reducing the PGs synthesis
Clinical uses of thiazides
- Hypertension
- CHF
- nephrolithiasis due to idiopathic hypercalciuria
- nephrogenic diabetes insipidus
Adverse effects of thiazides
- Hypokalemic metabolic alkalosis
- Hyperuricemia
- Hyperglycaemia
- Hyperlipidemia
- Hypoatremia
Examples of potassium-sparing diuretics
- spironolactone
- triamterene
- amiloride
- eplerenone
MOA of Spironolactone and Eplerenone
Competitively bind to aldosterone receptors in the late distal convoluted tubule and the collecting duct → inhibition of the effects of aldosterone → decreased Na+ reabsorption and K+ excretion → diuresis
MOA of triamterene and amiloride
direct inhibition of the epithelial sodium channels (ENaC) in the distal convoluted tubule and the collecting duct → reduced Na+ reabsorption and reduced K+ secretion → diuresis
PK of potassium-sparing diuretics
- spironolactone has a rather slow onset of action, requiring several days before full therapeutic effect is achieved
- triamterene is metabolised in the liver, shorter half-life and must be given frequently than amiloride, amiloride is excreted unchanged in the urine